Perrigo (PRGO) Free Cash Flow Growth (5y) (2018 - 2026)
Perrigo (PRGO) Free Cash Flow Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.91 Bn | 88.04 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.89 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Perrigo | 1.43 Bn | 1.07 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -23.03% |
| Dec 31, 2025 | 50.56% |
| Sep 27, 2025 | -13.57% |
| Jun 28, 2025 | -27.94% |
| Mar 29, 2025 | -21.54% |
| Dec 31, 2024 | 55.03% |
| Sep 28, 2024 | -32.07% |
| Jun 29, 2024 | -21.30% |
| Mar 30, 2024 | -18.75% |
| Dec 31, 2023 | -1.01% |
| Sep 30, 2023 | -8.50% |
| Jul 1, 2023 | -12.02% |
| Apr 1, 2023 | -15.14% |
| Dec 31, 2022 | -11.47% |
| Oct 1, 2022 | -11.39% |
| Jul 2, 2022 | -21.05% |
| Apr 2, 2022 | -19.37% |
| Dec 31, 2021 | 0.28% |
| Apr 3, 2021 | -22.05% |
| Sep 26, 2020 | -33.90% |